Michigan Tech Studying Better StentsResearchers at Michigan Technological University want to create a coronary artery stent that won't produce long term side effects. They think they may have found the answer in zinc.
Adeona Reports Positive Study Results For Zinc Treatment Of ALSPharma startup Adeona and its research partner report no safety issues related to high doses of zinc to slow the effects of Lou Gehrig's Disease
Adeona Loss Grows, But Drug Trials ContinueThe pharma startup Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, reported its third quarter 2011 financial results Monday.
HR Notices From August 25The latest personnel and boardroom announcements from Michigan's technology-focused companies and institutions
Adeona Loss Grows, But Milestones ReachedAnn Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.
Preventing Diabetes Damage: Zinc's Effects On A Kinky, Two-Faced CohortIn type 2 diabetes, a protein called amylin forms dense clumps that shut down insulin-producing cells, wreaking havoc on the control of blood sugar. But zinc has a knack for preventing amylin from misbehaving. Recent research at the University of Michigan offers new details about how zinc performs this "security guard" function.
Adeona Announces Positive Alzheimer's Subgroup AnalysisAnn Arbor-based Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) Thursday announced positive findings based on further analyses from the clinical study evaluating its product reaZin along with near-term plans for its Alzheimer's disease program.
Adeona's Alzheimer's Study Accepted For Neurology MeetingAnn Arbor-based Adeona Pharmaceuticals Inc. said Tuesday that an abstract on its pivotal clinical trial of its zinc and cysteine-based product candidate being evaluated in patients with Alzheimer's disease and mild cognitive impairment has been accepted for presentation at the 2011 American Academy of Neurology Annual Meeting in April.
Event Notices From January 18The latest event and meeting notices from Michigan's technology community, before they're posted on the GLITR IT Calendar
UM Study: 'Security Guard' Zinc Off Duty In Diabetes